Mushrooms / Psilocybin - OPEN Foundation

The ethics of psychedelic research in disorders of consciousness.

Peterson, A., Tagliazucchi, E., & Weijer, C. | Neuroscience of Consciousness | 9 October 2019

The psychedelic renaissance: the next trip for psychiatry?

Kelly, J. R., Baker, A., Babiker, M., Burke, L., Brennan, C., & O’Keane, V. | Irish journal of psychological medicine | 23 September 2019

Hallucinogens and Their Therapeutic Use: A Literature Review

BEGOLA, M. J., & SCHILLERSTROM, J. E. | Journal of Psychiatric Practice | September 2019

Psychedelic drugs-a new era in  psychiatry? 

Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | September 2019

Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects

Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. | NeuroImage | 1 August 2019

Classical psychedelics for the treatment of depression and anxiety: A systematic review.

Muttoni, S., Ardissino, M., & John, C. | Journal of affective disorders | 30 July 2019

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.

Kuypers, K. P., Ng, L., Erritzoe, D., Knudsen, G. M., Nichols, C. D., Nichols, D. E., ... & Nutt, D. | Journal of Psychopharmacology | 14 July 2019

Psychedelic microdosing benefits and challenges: an empirical codebook.

Anderson, T., Petranker, R., Christopher, A., Rosenbaum, D., Weissman, C., Dinh-Williams, L. A., ... & Hapke, E. | 10 July 2019 | Harm reduction journal

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 1 July 2019

Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives

Pallavicini, C., Vilas, M. G., Villarreal, M., Zamberlan, F., Muthukumaraswamy, S., Nutt, D., & Tagliazucchi, E. | NeuroImage | 24 June 2019

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 20 June 2019

Replication and extension of a model predicting response to psilocybin

Russ, S. L., Carhart-Harris, R. L., Maruyama, G., & Elliott, M. S. | Psychopharmacology | 15 June 2019

Collective self-experimentation in patient-led research: How online health communities foster innovation

Kempner, J., & Bailey, J. | Social Science & Medicine | 11 June 2019

Motives and side-effects of microdosing with psychedelics among users

Hutten, N. R., Mason, N. L., Dolder, P. C., & Kuypers, K. P. | International Journal of Neuropsychopharmacology | 31 May 2019

Psychedelic-assisted therapies: The past, and the need to move forward responsibly.

Gardner, J., Carter, A., O’Brien, K., & Seear, K. | International Journal of Drug Policy | 25 May 2019

Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin

Lord, L. D., Expert, P., Atasoy, S., Roseman, L., Rapuano, K., Lambiotte, R., & Cabral, J. | NeuroImage | 25 May 2019

Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.

Jefsen, O., Højgaard, K., Christiansen, S. L., Elfving, B., Nutt, D. J., Wegener, G., & Müller, H. K. | Acta neuropsychiatrica | 20 May 2019

Narrative identity, rationality, and microdosing classic psychedelics

Webb, M., Copes, H., & Hendricks, P. S. | International Journal of Drug Policy | 6 May 2019

Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature.

Rocha, J. M., Osório, F. L., Crippa, J. A. S., Bouso, J. C., Rossi, G. N., Hallak, J. E., & dos Santos, R. G. | Therapeutic advances in psychopharmacology | 26 April 2019

Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.

Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R. | PloS one | 23 April 2019